Intensity Therapeutics INTS
NASDAQ INTS
$3.42 -0.23 (-6.28%)
As of: Sep 29, 2026 · 3:55 PM EDT

Intensity Therapeutics (INTS) Cash from Financing Activities (2023 - 2026)

Updated

Intensity Therapeutics (INTS) reported Cash from Financing Activities of $1.62 million for Q2 2026, down 56.6% from $3.74 million a year earlier but up 982.7% from the prior quarter.

Analysis

Intensity Therapeutics (INTS) Cash from Financing Activities (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Intensity Therapeutics' Cash from Financing Activities came in at $16.27 million, up 133.7% year-over-year; for FY2025, it was $18.56 million, up 540.1% from FY2024.

  • Cash from Financing Activities has a three-year compound annual growth rate of 102.1% (FY2022 to FY2025).
  • By year, Cash from Financing Activities came in at $2.9 million in FY2024 (-85.8%), $20.47 million in FY2023 (+809.9%) and $2.25 million in FY2022.
  • Five-year quarterly Cash from Financing Activities spans a low of -$241,000 in Q2 2023 and a high of $20.52 million in Q3 2023.
  • Year over year, Cash from Financing Activities gained in 1 of the last four quarters, with an average decline of 4.0%.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $150,000 (Q1 2026), $7.26 million (Q4 2025) and $7.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -8.78 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -47.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 2.34 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -426.70 Mn
10 Intensity Therapeutics 10.75 Mn 10.75 Mn - 1.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Mn
Mar 31, 2026 150,000.00
Dec 31, 2025 7.26 Mn
Sep 30, 2025 7.24 Mn
Jun 30, 2025 3.74 Mn
Mar 31, 2025 328,000.00
Dec 31, 2024 2.48 Mn
Sep 30, 2024 413,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 8,000.00
Dec 31, 2023 -13,000.00
Sep 30, 2023 20.52 Mn
Jun 30, 2023 -241,000.00
Mar 31, 2023 205,000.00
API Access

Intensity Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=INTS&period=max&api_key=YOUR_API_KEY